652 related articles for article (PubMed ID: 34348019)
1. COVID-19 Infection: Targeting Possibilities for Treatment.
Haider T; Gour V; Pandey V; Kanwar IL; Tiwari R; Vishwakarma M; Bakshi AK; Sarkar A; Yadav R; Soni S; Soni V
Crit Rev Ther Drug Carrier Syst; 2021; 38(3):75-115. PubMed ID: 34348019
[TBL] [Abstract][Full Text] [Related]
2. COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.
Bhattacharyya P; Das S; Aich S; Sarkar J
Front Biosci (Elite Ed); 2021 Dec; 13(2):272-290. PubMed ID: 34937314
[TBL] [Abstract][Full Text] [Related]
3. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
Rohilla S
Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2: Targeted managements and vaccine development.
Bakhiet M; Taurin S
Cytokine Growth Factor Rev; 2021 Apr; 58():16-29. PubMed ID: 33293238
[TBL] [Abstract][Full Text] [Related]
5. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
Front Immunol; 2021; 12():658519. PubMed ID: 34276652
[TBL] [Abstract][Full Text] [Related]
6. Covid-19 pandemic: Perspectives on management.
Gathiram P; Moodley J; Khaliq OP
J Reprod Immunol; 2021 Aug; 146():103344. PubMed ID: 34146892
[TBL] [Abstract][Full Text] [Related]
7. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
[TBL] [Abstract][Full Text] [Related]
8. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
[TBL] [Abstract][Full Text] [Related]
9. In search of preventive strategies: novel high-CBD
Wang B; Kovalchuk A; Li D; Rodriguez-Juarez R; Ilnytskyy Y; Kovalchuk I; Kovalchuk O
Aging (Albany NY); 2020 Nov; 12(22):22425-22444. PubMed ID: 33221759
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.
Canedo-Marroquín G; Saavedra F; Andrade CA; Berrios RV; Rodríguez-Guilarte L; Opazo MC; Riedel CA; Kalergis AM
Front Immunol; 2020; 11():569760. PubMed ID: 33362758
[TBL] [Abstract][Full Text] [Related]
11. Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19.
Al-Bari AA
Curr Drug Targets; 2020; 21(16):1703-1721. PubMed ID: 32552642
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Role of Corona Virus based on Current Scientific Evidence - A Review with Emerging Importance in Pandemic.
Ray SK; Mukherjee S
Recent Pat Antiinfect Drug Discov; 2020; 15(2):89-103. PubMed ID: 32957894
[TBL] [Abstract][Full Text] [Related]
13. The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.
Younis NK; Zareef RO; Maktabi MAN; Mahfouz R
Genet Test Mol Biomarkers; 2021 Feb; 25(2):85-101. PubMed ID: 33596144
[TBL] [Abstract][Full Text] [Related]
14. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
Idrees M; Khan S; Memon NH; Zhang Z
Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
[TBL] [Abstract][Full Text] [Related]
15. FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy.
Drożdżal S; Rosik J; Lechowicz K; Machaj F; Kotfis K; Ghavami S; Łos MJ
Drug Resist Updat; 2020 Dec; 53():100719. PubMed ID: 32717568
[TBL] [Abstract][Full Text] [Related]
16. New Hopes for Drugs against COVID-19 Come from the Sea.
Taglialatela-Scafati O
Mar Drugs; 2021 Feb; 19(2):. PubMed ID: 33670191
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Different Therapeutic Interventions on Prevention and Treatment of COVID-19.
Gyanwali P; Sharma S; Pant S; Koirala P; Adhikari K; Koirala J; Dhimal M
J Nepal Health Res Counc; 2020 Sep; 18(2):151-158. PubMed ID: 32969369
[TBL] [Abstract][Full Text] [Related]
18. Pandemic COVID-19 caused by SARS-CoV-2: genetic structure, vaccination, and therapeutic approaches.
Marei HE; Althani A; Afifi N; Pozzoli G; Caceci T; Angelini F; Cenciarelli C
Mol Biol Rep; 2021 Sep; 48(9):6513-6524. PubMed ID: 34398427
[TBL] [Abstract][Full Text] [Related]
19. Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies.
Hassan M; Zalkifal M; Wahab A; Afzal S; Rafique S; Shahid M; Khan MA; Ahmed N; Idrees M; Shahid AA
Crit Rev Eukaryot Gene Expr; 2021; 31(3):21-34. PubMed ID: 34369712
[TBL] [Abstract][Full Text] [Related]
20. Favipiravir and COVID-19: A Simplified Summary.
Ghasemnejad-Berenji M; Pashapour S
Drug Res (Stuttg); 2021 Mar; 71(3):166-170. PubMed ID: 33176367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
